Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$19,054,180
+$1,306,563 QoQ
Shares Held
75,720
-7.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#630
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESBANCO BANK INC holds $195,633,177 across 11 Drug Manufacturers - General names. ABBV ranks #5 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,820 | $38,165,865 | |
| 2 | JNJ |
Johnson & Johnson
|
149,930 | $38,077,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
280,575 | $36,053,887 | |
| 4 | AMGN |
Amgen Inc
|
88,377 | $32,003,078 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
75,720 | $19,054,180 | |
| 6 | AZN |
Astrazeneca PLC
|
68,209 | $12,933,789 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
217,215 | $12,515,927 | |
| 8 | PFE |
Pfizer Inc
|
162,515 | $3,913,360 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,054,180 | 75,720 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $17,747,617 | 81,602 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $18,754,915 | 82,082 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $21,232,680 | 91,702 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $17,587,680 | 94,751 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $17,300,275 | 82,571 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $15,253,945 | 85,841 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $17,084,586 | 86,513 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $14,918,294 | 86,977 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $16,148,991 | 88,682 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,473,385 | 35,319 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $14,533,349 | 97,500 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $12,960,621 | 96,197 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $15,519,291 | 97,379 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $15,794,791 | 97,734 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $4,773,178 | 35,565 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $15,218,896 | 99,366 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $16,396,453 | 101,144 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $14,549,000 | 107,452 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $12,981,614 | 120,345 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $12,144,168 | 107,814 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $11,844,353 | 109,447 | Shares | Sole | 2021-05-06 | |
| 2020-09-30 | $11,119,111 | 126,945 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,591,093 | 128,245 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $5,655,964 | 74,235 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||